Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Operating Expenses | 751 | 965 | 288 | 2,412 | 59 |
| Operating Income | -689 | -965 | -288 | -2,412 | -59 |
| Interest Expense | 78 | 13 | 13 | 13 | 13 |
| Other Income | 21 | 335 | 363 | 1,045 | -11 |
| Pre-tax Income | -746 | -643 | 62 | -1,381 | -83 |
| Net Income Continuous | -746 | -643 | 62 | -1,381 | -83 |
| Net Income | $-746 | $-643 | $62 | $-1,381 | $-83 |
| EPS Basic Total Ops | -32.26 | 0.00 | -129.03 | -64.52 | N/A |
| EPS Basic Continuous Ops | -6.85 | -10.21 | 1.00 | -29.25 | -1.86 |
| EPS Diluted Total Ops | -32.26 | 0.00 | -129.03 | -64.52 | N/A |
| EPS Diluted Continuous Ops | -6.85 | -10.21 | 1.00 | -29.25 | -1.86 |
| EBITDA(a) | $-688 | $-965 | $-288 | $-2,412 | $-59 |